GRAL GRAIL, Inc.
Healthcare$68.96+2.63%ClosedMarket Cap: $2.96B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.09
P/S
18.47
EV/EBITDA
-7.95
DCF Value
$-39.15
FCF Yield
-10.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
-14.8%
Operating Margin
-348.7%
Net Margin
-253.2%
ROE
-16.4%
ROA
-14.1%
ROIC
-15.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $40.8M | 47.9% | $-135.8M | $-93.2M | $— | — |
| Q4 null | $43.6M | -25.5% | $-124.4M | $-99.2M | $— | — |
| FY null | $147.2M | -42.5% | $-534.2M | $-408.4M | $— | — |
| Q3 null | $36.2M | -37.9% | $-125.3M | $-89.0M | $— | — |
| Q2 null | $35.5M | -50.0% | $-158.9M | $-114.0M | $— | — |
| Q1 null | $31.8M | -62.6% | $-153.6M | $-106.2M | $— | — |
| Q4 null | $38.3M | -41.7% | $-136.9M | $-97.1M | $— | — |
| FY null | $125.6M | -62.1% | $-2.19B | $-2.03B | $— | — |
| Q3 null | $28.7M | -77.6% | $-183.5M | $-125.7M | $— | — |
| Q2 null | $32.0M | -56.0% | $-1.64B | $-1.59B | $— | — |
| Q1 null | $26.7M | -82.0% | $-227.4M | $-218.9M | $— | — |
| Q4 2023 | $30.3M | -61.5% | $-194.6M | $-5.5M | $-0.18 | — |